{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T06:53:48Z","timestamp":1781679228850,"version":"3.54.5"},"reference-count":19,"publisher":"Norwegian Medical Association","issue":"20","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tidsskr Nor Legeforen","Tidsskriftet"],"published-print":{"date-parts":[[2016,11,8]]},"DOI":"10.4045\/tidsskr.15.1297","type":"journal-article","created":{"date-parts":[[2016,11,10]],"date-time":"2016-11-10T09:05:16Z","timestamp":1478768716000},"page":"1736-8","source":"Crossref","is-referenced-by-count":6,"title":["Gir sterkere cannabis flere helseproblemer?"],"prefix":"10.4045","volume":"136","author":[{"given":"Vigdis","family":"Vindenes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f8rgen G.","family":"Bramness","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne Line","family":"Bretteville-Jensen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f8rg","family":"M\u00f8rland","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liliana","family":"Bachs","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2479","reference":[{"key":"ref=1","doi-asserted-by":"crossref","unstructured":"McLaren J, Swift W, Dillon P et al. Cannabis potency and contamination: a review of the literature. Addiction 2008; 103: 1100\u2009\u2013\u20099. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=18494838&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1111\/j.1360-0443.2008.02230.x","DOI":"10.1111\/j.1360-0443.2008.02230.x"},{"key":"ref=2","doi-asserted-by":"crossref","unstructured":"Niesink RJ, Rigter S, Koeter MW et al. Potency trends of \u03949-tetrahydrocannabinol, cannabidiol and cannabinol in cannabis in the Netherlands: 2005\u2009\u2013\u20092015. Addiction 2015; 110: 1941\u2009\u2013\u200950. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=26234170&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1111\/add.13082","DOI":"10.1111\/add.13082"},{"key":"ref=3","unstructured":"WHO. The health and social effects of nonmedical cannabis use. 2016. http:\/\/who.int\/substance_abuse\/publications\/cannabis_report\/en\/ (8.9.2016)."},{"key":"ref=4","doi-asserted-by":"crossref","unstructured":"Cascini F, Aiello C, Di Tanna G. Increasing delta-9-tetrahydrocannabinol (\u0394-9-THC) content in herbal cannabis over time: systematic review and meta-analysis. Curr Drug Abuse Rev 2012; 5: 32\u2009\u2013\u200940. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=22150622&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.2174\/1874473711205010032","DOI":"10.2174\/1874473711205010032"},{"key":"ref=5","doi-asserted-by":"crossref","unstructured":"Volkow ND, Baler RD, Compton WM et al. Adverse health effects of marijuana use. N Engl J Med 2014; 370: 2219\u2009\u2013\u200927. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=24897085&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1056\/NEJMra1402309","DOI":"10.1056\/NEJMra1402309"},{"key":"ref=6","unstructured":"EMCDDA. Europeisk narkotikarapport \u2013 trender og utviklinger. 2016. http:\/\/emcdda.europa.eu\/system\/files\/publications\/2637\/TDAT16001NON.pdf (8.9.2016)."},{"key":"ref=7","doi-asserted-by":"crossref","unstructured":"Freeman TP, Winstock AR. Examining the profile of high-potency cannabis and its association with severity of cannabis dependence. Psychol Med 2015; 45: 3181\u2009\u2013\u20099. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=26213314&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1017\/S0033291715001178","DOI":"10.1017\/S0033291715001178"},{"key":"ref=8","doi-asserted-by":"crossref","unstructured":"Hall W, Degenhardt L. The adverse health effects of chronic cannabis use. Drug Test Anal 2014; 6: 39\u2009\u2013\u200945. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=23836598&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1002\/dta.1506","DOI":"10.1002\/dta.1506"},{"key":"ref=9","unstructured":"SIRUS RAPPORT 3\/2013 Pasienter tatt inn i\u00a0behandling i\u00a02011 for problemer knyttet til bruk av narkotiske stoffer og vanedannende legemidler. https:\/\/fhi.no\/globalassets\/dokumenterfiler\/rapporter\/sirusrap.3.13.pdf (8.9.2016)."},{"key":"ref=10","doi-asserted-by":"crossref","unstructured":"Volkow ND, Swanson JM, Evins AE et al. Effects of cannabis use on human behavior, including cognition, motivation, and psychosis: a review. JAMA Psychiatry 2016; 73: 292\u2009\u2013\u20097. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=26842658&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1001\/jamapsychiatry.2015.3278","DOI":"10.1001\/jamapsychiatry.2015.3278"},{"key":"ref=11","doi-asserted-by":"crossref","unstructured":"van der Pol P, Liebregts N, Brunt T et al. Cross-sectional and prospective relation of cannabis potency, dosing and smoking behaviour with cannabis dependence: an ecological study. Addiction 2014; 109: 1101\u2009\u2013\u20099. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=24628797&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1111\/add.12508","DOI":"10.1111\/add.12508"},{"key":"ref=12","doi-asserted-by":"crossref","unstructured":"Perez-Reyes M, Di Guiseppi S, Davis KH et al. Comparison of effects of marihuana cigarettes to three different potencies. Clin Pharmacol Ther 1982; 31: 617\u2009\u2013\u200924. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=6280918&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1038\/clpt.1982.86","DOI":"10.1038\/clpt.1982.86"},{"key":"ref=13","doi-asserted-by":"crossref","unstructured":"Canfield DV, Dubowski KM, Whinnery JE et al. Increased cannabinoids concentrations found in specimens from fatal aviation accidents between 1997 and 2006. Forensic Sci Int 2010; 197: 85\u2009\u2013\u20098. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=20074884&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1016\/j.forsciint.2009.12.060","DOI":"10.1016\/j.forsciint.2009.12.060"},{"key":"ref=14","doi-asserted-by":"crossref","unstructured":"Vindenes V, Strand DH, Kristoffersen L et al. Has the intake of THC by cannabis users changed over the last decade? Evidence of increased exposure by analysis of blood THC concentrations in impaired drivers. Forensic Sci Int 2013; 226: 197\u2009\u2013\u2009201. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=23415163&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1016\/j.forsciint.2013.01.017","DOI":"10.1016\/j.forsciint.2013.01.017"},{"key":"ref=15","doi-asserted-by":"crossref","unstructured":"Di Forti M, Marconi A, Carra E et al. Proportion of patients in south London with first-episode psychosis attributable to use of high potency cannabis: a case-control study. Lancet Psychiatry 2015; 2: 233\u2009\u2013\u20098. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=26359901&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1016\/S2215-0366(14)00117-5","DOI":"10.1016\/S2215-0366(14)00117-5"},{"key":"ref=16","unstructured":"Gjerde H, Strand MC, M\u00f8rland J. Driving under the influence of non-alcohol drugs \u2013 an update part I: epidemiological studies. Forensic Sci Rev 2015; 27: 89\u2009\u2013\u2009113. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=26227253&dopt=Abstract"},{"key":"ref=17","doi-asserted-by":"crossref","unstructured":"Di Forti M, Sallis H, Allegri F et al. Daily use, especially of high-potency cannabis, drives the earlier onset of psychosis in cannabis users. Schizophr Bull 2014; 40: 1509\u2009\u2013\u200917. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=24345517&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1093\/schbul\/sbt181","DOI":"10.1093\/schbul\/sbt181"},{"key":"ref=18","doi-asserted-by":"crossref","unstructured":"Kuepper R, van Os J, Lieb R et al. Continued cannabis use and risk of incidence and persistence of psychotic symptoms: 10 year follow-up cohort study. BMJ 2011; 342: d738. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=21363868&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1136\/bmj.d738","DOI":"10.1136\/bmj.d738"},{"key":"ref=19","unstructured":"Tuv SS, Strand MC, Karinen R et al. Effect and occurrence of synthetic cannabinoids. Tidsskr Nor Legeforen 2012; 132: 2285\u2009\u2013\u20098. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=23736196&dopt=Abstract"}],"container-title":["Tidsskrift for Den norske legeforening"],"original-title":[],"language":"no","deposited":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T06:02:02Z","timestamp":1781676122000},"score":1,"resource":{"primary":{"URL":"https:\/\/tidsskriftet.no\/2016\/11\/kronikk\/gir-sterkere-cannabis-flere-helseproblemer"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,8]]},"references-count":19,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2016,11,8]]}},"URL":"https:\/\/doi.org\/10.4045\/tidsskr.15.1297","relation":{},"ISSN":["0029-2001","0807-7096"],"issn-type":[{"value":"0029-2001","type":"print"},{"value":"0807-7096","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,8]]}}}